arrow
T

Takumi Kumai

asahikawa medical university
H指数:24
被引数:1,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-associated antigen-reactive T cells and clinical outcomes in head and neck squamous cell carcinoma treated with pembrolizumab plus chemotherapy

头颈部鳞状细胞癌患者接受帕博利珠单抗联合化疗治疗后,肿瘤相关抗原反应性T细胞与临床结局的关系

2026-08-240
OA
Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter study

客观缓解率预测接受免疫检查点阻断治疗但非靶向治疗的复发性或转移性头颈鳞状细胞癌患者的生存:一项回顾性多中心研究

Cancer
IF5.1
2026-04-210
PRE
The efficacy and safety of docetaxel with cisplatin compared with other chemotherapies in definitive chemoradiotherapy for head and neck squamous cell carcinoma: a real-world study

多西他赛联合顺铂相较于其他化疗方案在头颈部鳞状细胞癌根治性放化疗中的疗效与安全性:一项真实世界研究

2026-02-200
OAAI
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
2020-12-2916
OAAI
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

PD-L1-specific辅助性T细胞表现出有效的抗肿瘤反应: 靶向头颈部鳞状细胞癌PD-L1的癌症免疫治疗新策略

2019-06-2012
OAAI